Press release
Global Enasidenib Market, Size, Share, Analysis Report & Forecast to 2026
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. AML is a form of blood cancer, that starts in the bone marrow and spreads throughout the body. The illness spreads quickly to other sections of the body.Free Sample Copy @ https://www.omrglobal.com/request-sample/enasidenib-market
Since the COVID-19 virus outbreak in December 2019, the disease spread to almost every country around the globe with the World Health Organization, declaring it a public health emergency. The global impacts of the coronavirus disease (COVID-19) had significantly affect the Enasidenib market in 2020.
Enasidenib is a drug that is used to treat adults with acute myeloid leukaemia (AML), who has an IDH2 mutation. When AML has affected again or has not improved after previous treatment, this medication is given.
A Full Report of Global Enasidenib Market is Available at:
https://www.omrglobal.com/industry-reports/enasidenib-market
The revenue share of the Enasidenib market will increase as the healthcare industry develops. The market will expand as people are becoming more aware of health issues, and better facilities are beingavailable. As a result, the market in developed regions will grow dramatically.
Symptoms of Enasidenib syndrome include fever, cough, trouble breathing, bone pain, rapid weight gain, or swelling in your arms, legs, underarms, groin, or neck.
In August 2017, Enasidenibis was approved by the U.S. Food and Drug Administration (FDA) for the treatment of geriatric patients with relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation as detected by an FDA-approved test .and IDHIFA wasalso approved in Australia and Canada in August 2017.
Global Enasidenib Market – Segmentation
By Type:
50mg
100mg
By Application:
Hospital
Pharmacy
Global Enasidenib Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Celgene Corporation
Agios Pharmaceuticals
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/enasidenib-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Enasidenib Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2418957 • Views: …
More Releases from Orion Market Research
Earbuds Market Will Exhibit an Impressive Expansion by 2024-2031 | Apple Inc., B …
The global earbuds market is anticipated to grow at an exponential CAGR of 21.3% during the forecast period. One of the key driving factors fuelling the market growth includes the growing competitiveness among the market players. The demand for earbuds has been growing continuously over the past few years which has grown the number of market players as well. The market players have been offering new earbuds every few months,…
Vitamin Fortified and Mineral Enriched Food and Beverage Market Increasing Deman …
The global vitamin fortified and mineral enriched food and beverage market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period. The growing awareness about nutrient deficiency such as vitamin A, D, iron, and other nutrients is boosting the global vitamin fortified and mineral enriched food and beverage market during the forecast period.
According to the World Health Organization (WHO), in 2019, around 29.9% of women aged…
Fortified Wine Market is Likely to Increase at a Significantly High CAGR during …
Fortified wine market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. The major factors contributing to the growth of the market include emerging demand for premium alcoholic beverages and growing disposable income across emerging countries. As per the State Council of the People's Republic of China, the country's per capita disposable income stood at $1,265 in the first three months of 2019, up 6.8%…
Fragrance Market Is Expected to Exhibit Significant Growth Over 2031 Internation …
The global fragrance market is anticipated to grow at a considerable CAGR of 4.5% during the forecast period. The growing number of Gen Z and millennials is one of the most important elements influencing the fragrance industry. Younger customers and millennials are becoming more interested in personal grooming and are willing to try new concepts and companies. With more disposable income and increased exposure to foreign lifestyle patterns, the younger generation is…
More Releases for Enasidenib
2022 Enasidenib Market Report- by Key Segments, Growth Size, Emerging Trends and …
Enasidenib Market report incorporates item types, market applications, geographic areas, and financial backers and providers. The overall statistical surveying gives a complete investigation of the business for the figure time frame. In addition, the examination incorporates a few divisions just as a full investigation of the market's patterns and critical determinants. Moreover, Enasidenib Market report assists you in overcoming the difficulties by applying various strategies.
Download FREE PDF of the Report…
Global Enasidenib Drugs Market Perspective with Study of Leading Players and Rev …
In this Enasidenib Drugs Market – Global Industry Analysis & Forecast to 2030 research report, the central factors driving the advancement of this industry were recorded and the business accessories and end overseers were indulgent. This statistical surveying Enasidenib Drugs report investigates and inspects the industry and determines a widely inclusive estimate of its development and its details. Another perspective that was efficient is the cost analysis of the prime…
Global Enasidenib Market Developments, Trends & Growth Forecast at impressive CA …
Looking at the current trends across the Enasidenib market, a new study has been included to the wide database of Market Research Hub (MRH). The assessment is titled "Global Enasidenib Market Insights, Forecast to 2025", which discourses the various market impacting factors like drivers, restraints and opportunities. Moreover, readers are informed about the competitive landscape which enlightens about the different players operating in the Enasidenib market together with their market…
Global Enasidenib Drugs Market, Size, Industry Player (50mg, 100mg, Market Size …
The global market scenario for Enasidenib Drugs sector is carefully assessed through a smart study included to the broad database controlled by Market Research Hub (MRH). The assessment is titled “Global Enasidenib Drugs Market Insights, Forecast to 2025”, which actively provides information related to the growth trends and development opportunities during the forecasted period until 2025. Enasidenib is a drug used to treat relapsed or refractoryacute myeloid leukemiain people with…
Global Enasidenib Drugs Market Report 2018-2025 | Segmantation by Industry Surve …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
In 2018, the global Enasidenib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the…
Global Enasidenib Market Report 2018: Top Manufacturers, Regions, Type and Appli …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
In 2018, the global Enasidenib market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base…
